New Therapies areas will be established

when more innovations can support each other

Knowledge is essential when selling medical products, knowledge is undoubtedly important when selling new innovative products, and in general, knowledge is vital to gain the respect of healthcare professionals. Therefore, CoopMed divides the sales structures and concepts around therapy areas. Amongst others, these sales concepts can determine competition levels between member products.

Wound Healing

Healing Wounds takes more than just one product

Caring for patients with chronic wounds is a significant challenge, involving clinicians from a wide range of areas of medicine with different levels of education.

To make the very complex processes of diagnosis and treatment of these patients understandable, different models are available to the health care professionals.

The T.I.M.E concept (tissue, infection, moisture, edge), published in 2003, and expanded to TIMERS in 2018 (including regeneration of tissue, social factors) is undoubtedly at the center of attention.

As a guide for local therapy of chronic wounds, Wund-D.A.CH., the umbrella organization of German-speaking wound healing societies, also provided M.O.I.S.T. presented a new concept for local treatment of chronic wounds.

All these concepts serve to illustrate the highly complex, interdisciplinary process of wound healing and to create a uniform nomenclature for the treatment of these wounds.

The CoopMed wound model is true to these models and very visualizes merely the most critical steps in the care of people with hard-to-heal / chronic wounds.

The key to effectively heal wounds

The keys to effectively heal wounds are well-educated health care professionals able to diagnose the wound and patient-related factors like

  • Malnutrition
  • Cardiovascular disorders
  • Medication (e.g., non-steroidal anti-inflammatory drugs, corticosteroids)
  • Obesity
  • Microbial colonization of the wound
  • Systemic disorders (e.g., diabetes, autoimmune conditions)
  • Unrelieved pressure on the wound
  • Maceration due to excess wound exudate or other moisture
  • Inappropriate wound management
  • Patient compliance with the wound care regimen
  • Immobility

Based on that diagnose, nurses will formulate a treatment plan ,including indication-specific essential focus options where needed, like offloading for Diabetic Foot Ulcers or compression for Venous Leg Ulcers, not to mention:

  • Fighting critical barriers to wound healing such as Necrotic tissue, slough, bacteria, biofilm, virus, infections, and multidrug resistance organisms
  • Accelerating healing of stalled wounds by using active ingredients

Besides, the health care professional also needs to pick the right dressing to cover the wound that ensures the proper moisture level at any point in time.

It is a complicated process that needs skilled eyes, which we have tried to visualize and simplify in the CoopMed Wound Model.

Many different products from established manufacturers are already available to clinicians. But as innovation levels within the industry historically are relatively low, CoopMed aims to focus on a portfolio of synergistic innovative products from start-up companies who do not have the resources of large companies.

To improve future healing rates, we believe that you need to focus more on the education of healthcare professionals and Active Wound Healing concepts.

The barriers to wound healing are many

When selecting suitable products for this concept, CoopMed is supported by a board of clinical consultants made up of international experts from various wound healing related disciplines.

Healthcare-associated infections

Bacteria, viruses, infections, and multidrug-resistant organisms are a fact of life in healthcare settings

Infection Control is a major and very important focus area of any institution, and within healthcare, it is often referred to as HAI; Hospital-Acquired Infections (or nosocomial infections), meaning infections acquired specifically at the hospital/healthcare setting, or as the slightly broader term Healthcare-Associated Infections. In our model, we have chosen a broader understanding of infections related to healthcare.

Infection Control Management certainly needs to focus on clean hands, gloves, surgical gowns, clean surgical rooms, equipment, and wards – surfaces – clean surgical tools, but also medical devices that hold the risk of transporting bacteria or virus into the body.

Such a broad focus on cleanliness or even sterile conditions requires a lot from both support products and procedural compliance. It is a discipline of its own.

Many different products from established manufacturers are already available to clinicians but, as innovation levels within the industry historically are relatively low, CoopMed aims to focus on a portfolio of innovative products and support solutions from start-up companies.

To reduce infection levels, we believe that we not only need to focus on new products but also on support tools to improve compliance of healthcare personnel to infection control procedures.


Dementia is projected to become a leading cause of death and health care costs

Dementia is one of the largest healthcare challenges of our time. Currently, 1 in 3 seniors die of dementia in the US and globally 50 million people are diagnosed with dementia – and unfortunately, this figure is expected to more than triple to 152 million people by 2050. As we generally live longer and the prevention and treatment of the most common causes of death such as cancer and heart disease are getting more efficient, dementia is expected to become a leading cause of death by 2030 and is already the leading cause of death for women in the UK.

Dementia puts an enormous emotional burden on the patients and their loved ones as cognitive abilities deteriorate, behaviours change, and independence is lost. It is also a massive and increasing financial burden on society and our health care systems with an accumulated global cost upwards of 1 trillion USD globally today and expected to double to 2 trillion USD within decades, and eventually expected to eclipse the cost of cancer and heart disease.

Participating start-ups and niche players

Coopmed was established in August 2020 and have had a lot of attention from incubator environments already.
The first cooperation agreement was ready from the start.

EXELDERMA (July 2021)

SoftOx Solutions (Aug. 2020)

JeNaCell (September 2022)

Brain+ (September 2022)